Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination.
Saved in:
| Title: | Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination. |
|---|---|
| Authors: | Wall, Emma C (AUTHOR), Wu, Mary (AUTHOR), Harvey, Ruth (AUTHOR), Kelly, Gavin (AUTHOR), Warchal, Scott (AUTHOR), Sawyer, Chelsea (AUTHOR), Daniels, Rodney (AUTHOR), Hobson, Philip (AUTHOR), Hatipoglu, Emine (AUTHOR), Ngai, Yenting (AUTHOR), Hussain, Saira (AUTHOR), Nicod, Jerome (AUTHOR), Goldstone, Robert (AUTHOR), Ambrose, Karen (AUTHOR), Hindmarsh, Steve (AUTHOR), Beale, Rupert (AUTHOR), Riddell, Andrew (AUTHOR), Gamblin, Steve (AUTHOR), Howell, Michael (AUTHOR), Kassiotis, George (AUTHOR) |
| Source: | Lancet. 6/19/2021, Vol. 397 Issue 10292, p2331-2333. 3p. |
| Subjects: | COVID-19 vaccines, SARS-CoV-2, Vaccination, Immunoglobulins |
| Database: | Psychology and Behavioral Sciences Collection |
Be the first to leave a comment!
